Agreed CDiddy. Hard not to notice how all three o
Post# of 148166
With all of the discussions relating to Dr. Patterson possibly performing tests and having optics on the blinded blood samples, I have considered the possibility that he developed an assay that indicates the presence (or not) of leronlimab in blood samples.
That would preclude the need for any guessing game regarding which subjects were reacting to the drug versus placebo. Of course, he wouldn't have access to all of the other clinical data, but maybe that's enough for them to feel like they nailed it.